Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-1-piperidinyl)hexanoate
2. Ati 7505
3. Ati-7505
4. Ati7505
1. 860174-12-5
2. Ati-7505
3. Naronapride [usan:inn]
4. Naronapride Free Base
5. Ati7505
6. Unii-058896b00b
7. Ati 7505
8. 058896b00b
9. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-1-piperidinyl)hexanoate
10. 1-piperidinehexanoic Acid, 4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-, (3r)-1-azabicyclo(2.2.2)oct-3-yl Ester, (3s,4r)-
11. Naronapride [usan]
12. [(3r)-1-azabicyclo[2.2.2]octan-3-yl] 6-[(3s,4r)-4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-3-methoxypiperidin-1-yl]hexanoate
13. Naronapride [inn]
14. Naronapride (usan/inn)
15. Naronapride [who-dd]
16. Schembl731063
17. Chembl2103858
18. Dtxsid401006590
19. 860174-12-5 (free Base)
20. Db05542
21. Hy-121826
22. Cs-0083508
23. Ns00071036
24. D09933
25. Q27236096
26. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2- Methoxybenzoyl)amino)-3-methoxypiperidin-1-yl)hexanoate
27. (r)-quinuclidin-3-yl 6-((3s,4r)-4-(4-amino-5-chloro-2-methoxybenzamido)-3-methoxypiperidin-1-yl)hexanoate
28. 1-piperidinehexanoic Acid, 4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-, 1-azabicyclo(2.2.2)oct-3-yl Ester, (3s,4r)-
29. 4-amino-n-(1-{6-[(1-azabicyclo[2.2.2]octan-3-yl)oxy]-6-oxohexyl}-3-methoxypiperidin-4-yl)-5-chloro-2-methoxybenzene-1-carboximidic Acid
1. Naronapride Free Base
2. Ati-7505
3. Cas 860174-12-5
4. Ati 7505
5. 860174-12-5
| Molecular Weight | 537.1 g/mol |
|---|---|
| Molecular Formula | C27H41ClN4O5 |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 12 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 106 |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 752 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in gastroesophageal reflux disease (GERD) and gastroparesis.
Serotonin 5-HT4 Receptor Agonists
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS. (See all compounds classified as Serotonin 5-HT4 Receptor Agonists.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
80
PharmaCompass offers a list of Naronapride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Naronapride manufacturer or Naronapride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naronapride manufacturer or Naronapride supplier.
PharmaCompass also assists you with knowing the Naronapride API Price utilized in the formulation of products. Naronapride API Price is not always fixed or binding as the Naronapride Price is obtained through a variety of data sources. The Naronapride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Naronapride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naronapride, including repackagers and relabelers. The FDA regulates Naronapride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naronapride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Naronapride supplier is an individual or a company that provides Naronapride active pharmaceutical ingredient (API) or Naronapride finished formulations upon request. The Naronapride suppliers may include Naronapride API manufacturers, exporters, distributors and traders.
Naronapride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naronapride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naronapride GMP manufacturer or Naronapride GMP API supplier for your needs.
A Naronapride CoA (Certificate of Analysis) is a formal document that attests to Naronapride's compliance with Naronapride specifications and serves as a tool for batch-level quality control.
Naronapride CoA mostly includes findings from lab analyses of a specific batch. For each Naronapride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naronapride may be tested according to a variety of international standards, such as European Pharmacopoeia (Naronapride EP), Naronapride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naronapride USP).
